T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
暂无分享,去创建一个
E. Nagel | G. Carr-White | R. Gebker | A. Zeiher | E. Herrmann | S. Kelle | V. Puntmann | Chung-yao Yu | D. Dabir | A. Doltra | Toby Rogers | A. Jabbour | R. Hinojar | Nicholas M. Child | Sitara G. Khan | N. Varma | Benjamin P Goodman | E. Arroyo Úcar | G. Suna | T. Rogers | G. Carr-white
[1] E. Nagel,et al. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. , 2015, Circulation. Cardiovascular imaging.
[2] Eric E. Smith,et al. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). , 2015, Circulation.
[3] P. Matthews,et al. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. , 2015, JACC. Cardiovascular imaging.
[4] M. Mayr,et al. T1 values by conservative septal postprocessing approach are superior in relating to the interstitial myocardial fibrosis: findings from patients with severe aortic stenosis , 2015, Journal of Cardiovascular Magnetic Resonance.
[5] Yong-Jin Kim,et al. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. , 2015, Radiology.
[6] M. Mayr,et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. , 2015, JACC. Cardiovascular imaging.
[7] David M Higgins,et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study , 2014, Journal of Cardiovascular Magnetic Resonance.
[8] E. Nagel,et al. Aortic Stiffness and Interstitial Myocardial Fibrosis by Native T1 Are Independently Associated With Left Ventricular Remodeling in Patients With Dilated Cardiomyopathy , 2014, Hypertension.
[9] V. Fuster,et al. The MOGE(S) classification of cardiomyopathy for clinicians. , 2014, Journal of the American College of Cardiology.
[10] P. Kellman,et al. T1-mapping in the heart: accuracy and precision , 2014, Journal of Cardiovascular Magnetic Resonance.
[11] Scott D Flamm,et al. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update , 2013, Journal of Cardiovascular Magnetic Resonance.
[12] Tobias Schaeffter,et al. Standardization of T1 measurements with MOLLI in differentiation between health and disease – the ConSept study , 2013, Journal of Cardiovascular Magnetic Resonance.
[13] Stefan Neubauer,et al. T1 measurements in the human myocardium: The effects of magnetization transfer on the SASHA and MOLLI sequences , 2013, Magnetic resonance in medicine.
[14] W. Stevenson,et al. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[15] Tiina Heliö,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[16] P. Kellman,et al. T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision , 2013, Journal of Cardiovascular Magnetic Resonance.
[17] Karl Swedberg,et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. , 2013, European heart journal.
[18] Scott D Flamm,et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing , 2013, Journal of Cardiovascular Magnetic Resonance.
[19] Reza Razavi,et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[20] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[21] E. Nagel,et al. Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.
[22] Andrew S Flett,et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.
[23] Ivan C. Gerling,et al. Myofibroblast-mediated mechanisms of pathological remodelling of the heart , 2013, Nature Reviews Cardiology.
[24] James O. Mudd,et al. T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. , 2012, Radiology.
[25] P. Kellman,et al. Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.
[26] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[27] Pierre Croisille,et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. , 2011, Journal of the American College of Cardiology.
[28] Sandeep N. Gupta,et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.
[29] Michael Jerosch-Herold,et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.
[30] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[31] Renu Virmani,et al. A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .